418 related articles for article (PubMed ID: 29093509)
1. Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.
Patrone V; Puglisi E; Cardinali M; Schnitzler TS; Svegliati S; Festa A; Gabrielli A; Morelli L
Sci Rep; 2017 Nov; 7(1):14874. PubMed ID: 29093509
[TBL] [Abstract][Full Text] [Related]
2. Update on the Gastrointestinal Microbiome in Systemic Sclerosis.
Bellocchi C; Volkmann ER
Curr Rheumatol Rep; 2018 Jun; 20(8):49. PubMed ID: 29943234
[TBL] [Abstract][Full Text] [Related]
3. Dysbiosis and Gut Microbiota Modulation in Systemic Sclerosis.
Lemos MPC; Zucoloto TG; Oliveira MC; de Oliveira GLV
J Clin Rheumatol; 2022 Mar; 28(2):e568-e573. PubMed ID: 34030162
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome.
Nguyen AD; Andréasson K; McMahan ZH; Bukiri H; Howlett N; Lagishetty V; Lee SM; Jacobs JP; Volkmann ER
Semin Arthritis Rheum; 2023 Jun; 60():152185. PubMed ID: 36870237
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status.
Natalello G; Bosello SL; Paroni Sterbini F; Posteraro B; De Lorenzis E; Canestrari GB; Gigante L; Verardi L; Ferraccioli G; Sanguinetti M; Gremese E
Clin Exp Rheumatol; 2020; 38 Suppl 125(3):73-84. PubMed ID: 32865168
[TBL] [Abstract][Full Text] [Related]
6. Intestinal microbiome in scleroderma: recent progress.
Volkmann ER
Curr Opin Rheumatol; 2017 Nov; 29(6):553-560. PubMed ID: 28719392
[TBL] [Abstract][Full Text] [Related]
7. The microbiome and systemic sclerosis: A review of current evidence.
Tan TC; Noviani M; Leung YY; Low AHL
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101687. PubMed ID: 33849778
[TBL] [Abstract][Full Text] [Related]
8. Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease.
Andréasson K; Alrawi Z; Persson A; Jönsson G; Marsal J
Arthritis Res Ther; 2016 Nov; 18(1):278. PubMed ID: 27894337
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis.
McMahan ZH; Tucker AE; Perin J; Volkmann ER; Kulkarni S; Ziessman HA; Pasricha PJ; Wigley FM
Arthritis Care Res (Hoboken); 2022 Mar; 74(3):442-450. PubMed ID: 33064934
[TBL] [Abstract][Full Text] [Related]
10. Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study.
Shi Z; Qiu Y; Wang J; Fang Y; Zhang Y; Chen H; Du Q; Zhao Z; Yan C; Yang M; Zhou H
J Neuroimmunol; 2020 Feb; 339():577126. PubMed ID: 31841737
[TBL] [Abstract][Full Text] [Related]
11. The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential.
Kim S; Park HJ; Lee SI
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555792
[TBL] [Abstract][Full Text] [Related]
12. Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium.
Volkmann ER; Chang YL; Barroso N; Furst DE; Clements PJ; Gorn AH; Roth BE; Conklin JL; Getzug T; Borneman J; McGovern DP; Tong M; Jacobs JP; Braun J
Arthritis Rheumatol; 2016 Jun; 68(6):1483-92. PubMed ID: 26749064
[TBL] [Abstract][Full Text] [Related]
13. Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial.
Marighela TF; Arismendi MI; Marvulle V; Brunialti MKC; Salomão R; Kayser C
Rheumatology (Oxford); 2019 Nov; 58(11):1985-1990. PubMed ID: 31056685
[TBL] [Abstract][Full Text] [Related]
14. Microbial and metabolic multi-omic correlations in systemic sclerosis patients.
Bellocchi C; Fernández-Ochoa Á; Montanelli G; Vigone B; Santaniello A; Milani C; Quirantes-Piné R; Borrás-Linares I; Ventura M; Segura-Carrettero A; Alarcón-Riquelme ME; Beretta L
Ann N Y Acad Sci; 2018 Jun; 1421(1):97-109. PubMed ID: 29749635
[TBL] [Abstract][Full Text] [Related]
15. Dysbiosis signatures of gut microbiota in coronary artery disease.
Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
[TBL] [Abstract][Full Text] [Related]
16. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
[TBL] [Abstract][Full Text] [Related]
17. Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts.
Suliman Y; Kafaja S; Oh SJ; Alemam M; Bagnato G; Abignano G; Singh RR; Barlow G; Liu X; Valera I; Morales W; Rezaie A; Pimentel M; Del Galdo F; Furst DE
Clin Rheumatol; 2021 Jun; 40(6):2277-2284. PubMed ID: 33231773
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome profiling in systemic sclerosis: a metagenomic approach.
Tan TC; Chandrasekaran L; Leung YY; Purbojati R; Pettersson S; Low AHL
Clin Exp Rheumatol; 2023 Aug; 41(8):1578-1588. PubMed ID: 36826808
[TBL] [Abstract][Full Text] [Related]
19. Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility.
Yang M; Fukui H; Eda H; Xu X; Kitayama Y; Hara K; Kodani M; Tomita T; Oshima T; Watari J; Miwa H
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G367-G373. PubMed ID: 28154011
[TBL] [Abstract][Full Text] [Related]
20. Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis.
Plichta DR; Somani J; Pichaud M; Wallace ZS; Fernandes AD; Perugino CA; Lähdesmäki H; Stone JH; Vlamakis H; Chung DC; Khanna D; Pillai S; Xavier RJ
Genome Med; 2021 Feb; 13(1):35. PubMed ID: 33648559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
